medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 4

<< Back Next >>

Med Int Mex 2020; 36 (4)

Characteristics of health care-associated infections in a high specialty hospital of Yucatan, Mexico

Torres-Erazo D, Núñez-Caamal N, Villalobos-Díaz R, Durán-Falcón M

Language: Spanish
References: 39
Page: 451-459
PDF size: 243.22 Kb.


ABSTRACT

Background: Health care-associated infections are a serious issue regarding public health, due to the impact in morbidity, mortality and hospitality costs.
Objective: To determine the prevalence and microbiological characteristics of health care-associated infections in the High Specialty Regional Hospital of Yucatan, Mexico.
Material and Method: A cross-sectional and descriptive study was done from January to December 2017. The total cases of health care-associated infections documented by the epidemiology department were selected, according to the NOM-045. We obtained cultures and antimicrobial susceptibility testing from the microbiology department of High Specialty Regional Hospital of Yucatan, Mexico.
Results: A total of 225 cases of health care-associated infections were identified, obtaining a rate of 7.25/1000 days of hospital stay. The medical service with highest prevalence was Internal Medicine with 67 cases (29.7%), and the most frequent infection site was catheter associated-urinary tract infections with 64 cases (28%). We obtained microbiologic cultures in 206 patients, of which 75.7% were gramnegative bacteria, of these, E. coli was predominant with 61 cases (29.6%).
Conclusion: The epidemiological and microbiological characterization of health care-associated infections is fundamental for the development of preventive strategies aimed at reducing their impact on public and institutional health since they are a dynamic phenomenon over time, even within the same hospital or hospital service.


REFERENCES

  1. World Health Organization. Report on the burden of endemic health care-associated infection worldwide. WHO Library 2011.

  2. Organización Panamericana de la Salud. Vigilancia epidemiológica de las infecciones asociadas a la atención de la salud. Módulo III: información para gerentes y personal directivo. OPS 2012.

  3. Murni I, Duke T, Triasih R, Kinney S, Daley AJ, Soenarto Y. Prevention of nosocomial infections in developing countries, a systematic review. Paediatr Int Child Health 2013; 33(2): 61-78. doi: 10.1179/2046905513Y.0000000054

  4. Allegranzi B, Bagheri NS, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care associated infections in developing countries: a systematic review and meta-analysis. Lancet 2011; 377: 288-41. https://doi.org/10.1016/S0140-6736(10)61458-4

  5. Mehrad B, Clark NM, Zhanel GG, Lynch JP. Antimicrobial resistance in hospital- acquired gram negative bacterial infections. Chest 2015; 147(5): 1413-1421. doi: 10.1378/ chest.14-2171

  6. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302(21): 2323-2329. doi: 10.1001/jama.2009.1754

  7. Calfee D. Trends in community versus health care-acquired methicilin-resistance Staphylococcus aureus infections. Curr Infect Dis Rep 2017; 19: 48. doi: 10.1007/s11908- 017-0605-6

  8. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin Resistant Staphylococcus aureus, 2014. CDC 2014; 1-3.

  9. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. World Health Organization 2014.

  10. Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis 2014; 78(4): 443-8. doi: 10.1016/j.diagmicrobio. 2013.11.025

  11. Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. Morb Mortal Wkly Rep. 2013; 62 (9): 165-170.

  12. Golan Y. Empiric therapy for hospital-acquired, gramnegative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options. BMC Infect Dis 2015; 15: 313. doi: 10.1186/s12879-015-1054-1

  13. Red Hospitalaria de Vigilancia Epidemiológica. Informe Anual 2015 de la Red Hospitalaria de Vigilancia Epidemiológica. Secretaría de Salud, México, 2016: 9-10.

  14. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 23rd ed. Document M100-S23.

  15. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Medición de la Prevalencia de Infecciones Nosocomiales en Hospitales Generales de las Principales Instituciones Públicas de Salud. Secretaría de Salud 2011: 15-49.

  16. Torres D, Domínguez J, Buenfil L, Cicero M. Características clínicas y microbiológicas de pacientes con infecciones asociadas a los cuidados de la salud en un hospital de alta especialidad de Yucatán. Enf Inf Microbiol 2018; 38(2): 44-49.

  17. Galiczewzki JM. Interventions for the prevention of catheter associated urinary tract infections in intensive care unit: an integrative review. Intensive Crit Care Nurs 2016; 32: 1-11. doi: 10.1016/j.iccn.2015.08.007

  18. Li F, Song M, Xu Linxia, Deng B, Zhu S, Li X. Risk factors for catheter-associated urinary tract infection among hospitalized patients: a systematic review and meta-analysis of observational studies. J Adv Nurs 2019. doi: 10.1111/ jan.13863

  19. Chenoweth C, Gould C, Saint S. Diagnosis, management, and prevention of catheter-associated urinary tract infections. Infect Dis Clin North Am 2014; 28:105-119. doi: 10.1016/j.idc.2013.09.002

  20. Cheon S, Kim MJ, Yun SJ, Moon JY, Kim YS. Controlling endemic multidrug-resistance Acinetobacter baumanii in intensive care units using antimicrobial stewardship and infection control. Korean J Intern Med 2016; 31: 367-374. doi: 10.3904/kjim.2015.178

  21. Baur D, Gladstone BP, Burket F, Carrara E, Foschi F, Döbele S, Tacoconelli E. Effect of antibiotic stewardship on the incidence of infection and colonization with antibioticresistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017; 17: 990-1001. doi: 10.1016/S1473-3099(17)30325-0

  22. Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, et al. Chlorhexidine bathing and health careassociated infections: a randomized clinical trial. JAMA 2015; 313(4): 369-378. doi: 10.1001/jama.2014.18400

  23. Frost SA, Hou YC, Lombardo L, Metcalfe L, Lynch JM, Hunt L, et al. Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive-care patient: a trial sequential meta-analysis. BMC Infects Dis 2018; 18: 679. doi: 10.1186/s12879-018- 3521-y

  24. Peleg Y, Hooper C. Hospital-acquired infections due to gram negative bacteria. N Engl J Med 2010; 362 (19): 1801-1813. doi: 10.1056/NEJMra0904124

  25. Tandogdu Z, Wagenlehner, F. Global epidemiology of urinary tract infections. Curr Opin Infect Dis 2016; 29 (1): 73-79. doi: 10.1097/QCO.0000000000000228

  26. Huang LF, Lo YC, Su LH, Chang CL. Antimicrobial susceptibility patterns among Escherichia coli urinary isolates from community-onset health care-associated urinary tract infection. J Formosan Med Assoc 2014. https://doi. org/10.1016/j.jfma.2014.01.009

  27. Hadifar S, Moghoofei M, Nematollahi S, Ramazanzadeh R, Sedighi M, Salehi-Abargouei A, et al. Epidemiology of multidrug resistant uropathogenic Escherichia coli in Iran: A systematic review and meta-analysis. Jpn Infect Dis 2017; 70 (1): 19-25. doi: 10.7883/yoken.JJID.2015.652

  28. Vega S, Dowzicky MJ. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the tigecycline evaluation and surveillance trial. Ann Clin Microbiol Antimicrob 2017; 16: 50. doi: 10.1186/ s12941-017-0222-0

  29. Jarvis WR, Jarvis AA, Chinn R. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 2012; 40: 194-200. https://doi.org/10.1016/j. ajic.2012.02.001

  30. Guzmán M, Mejía C, Isturiz R, Álvarez C, Bavestrello L, Gotuzzo E, et al. Epidemiology of meticilin-resistance Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents 2009; 34: 304-308. doi: 10.1016/j. ijantimicag.2009.06.005

  31. Arias C, Murray B. The rise of the Enteroccocus: beyond vancomycin resistance. Nat Rev Microbiol 2012; 10 (4): 266-278. doi: 10.1016/j.ijantimicag.2009.06.005

  32. Cercenado E. Enterococcus: resistencias fenotípicas y genotípicas y epidemiología en España. Enferm Infecc Microbiol Clin 2011;29 (Supl 5):59-65. DOI: 10.1016/ S0213-005X(11)70045-3

  33. Pitout J, Laupland K. Extended-spectrum B-lactamaseproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-166. doi: 10.1016/ S1473-3099(08)70041-0

  34. Ponce A, Rodríguez E, Morfin R, Cornejo D, Tinoco JC, Martínez A, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009- 2010. Infect Control Hosp Epidemiol 2013;34(1):1-14. doi: 10.1086/668770

  35. Jacoby G, Munoz-Price L. The new B-lactamase. N Engl J Med 2005; 352: 380-391. doi: 10.1056/NEJMra041359

  36. Septimus EJ. Antimicrobial resistance: An antimicrobial/ diagnostic stewardship and infection prevention approach. Med Clin North Am 2018; 102 (5): 819- 829. doi: 10.1016/j. mcna.2018.04.005

  37. Inweregbu K, Dave J, Pittard A. Nosocomial infections. Continuing Educ Anaesth Crit Care Pain 2005; 5: 14-1. https://doi.org/10.1093/bjaceaccp/mki006

  38. Lee C, Cho I, Jeong B, Lee S. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health 2013; 10: 4274- 4305. doi: 10.3390/ijerph10094274

  39. Diaz LM, Medina M, Duque AC, Migueléz R. Aspectos clínico-epidemiológicos de pacientes con infecciones asociadas a la salud. Rev Cubana Med 2017; 56(3):197-210.




2020     |     www.medigraphic.com